(Q45327633)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Michael Wagner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mats Stridsberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christer G B Peterson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Per Sangfelt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marie Carlson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

855-861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23423580%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10753-013-9612-4

24 February 2020

exact match

0 references

cites work

The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Role of neuropeptides in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Secretoneurin: A new peptide in the human enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Intrinsic primary afferent neurons and nerve circuits within the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Budesonide treatment of patients with collagenous colitis restores normal eosinophil and T-cell activity in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Multiple microcarcinoids in a patient with long standing ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Multifocal microcarcinoid tumours in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

A simple method for assessing intestinal inflammation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Secretoneurin is released into human airways by topical histamine but not capsaicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Secretoneurin increases monolayer permeability in human coronary artery endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

The neuropeptide secretoneurin acts as a direct angiogenic cytokine in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Vascular endothelial growth factor (VEGF)--a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Mechanisms of diarrhea in collagenous colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-013-9612-4

Measurements of chromogranin B can serve as a complement to chromogranin A

21 January 2018

1 reference

12 December 2020

Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis

1 reference

12 December 2020

Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin

1 reference

12 December 2020

The enteric nervous system

1 reference

12 December 2020

Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.

1 reference

12 December 2020

Collagenous colitis: an ultrastructural study of a case

1 reference

12 December 2020

Collagenous colitis: histologic, morphometric, immunohistochemical and ultrastructural studies. Report of 21 cases

1 reference

12 December 2020

Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma

1 reference

12 December 2020

Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.

1 reference

12 December 2020

Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils

1 reference

12 December 2020

Immunoelectron microscopic study of the luminal release of chromogranin A from rat enterochromaffin cells

1 reference

12 December 2020

Immunomorphological characteristics of mucosal and endocrine cells of the colon in patients with chronic ulcerative colitis

1 reference

12 December 2020

Collagenous colitis. Ultrastructural study and collagen immunotyping of four cases

1 reference

12 December 2020

Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

1 reference

12 December 2020

Eosinophil-nerve interactions and neuronal plasticity in rat gut associated lymphoid tissue (GALT) in response to enteric parasitism

1 reference

12 December 2020

Innervation of mucosal immune cells in the gastrointestinal tract

1 reference

12 December 2020

Rectal carcinoid arising in ulcerative colitis associated with rectal adenocarcinoma

1 reference

12 December 2020

Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function

1 reference

12 December 2020

Colonic endocrine cells in inflammatory bowel disease

1 reference

12 December 2020

Argyrophilic cell hyperplasia and an atypical carcinoid tumor in chronic ulcerative colitis

1 reference

12 December 2020

Plasma chromogranin a in patients with inflammatory bowel disease

1 reference

12 December 2020

Neutrophil-mediated gastrointestinal injury

1 reference

12 December 2020